A comprehensive view of Drug Delivery / Ingestion. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Medincell enters into strategic co-development and licensing agreement with AbbVie to develop next-generation long-acting injectable therapies; deal includes development of up to six injectables across multiple therapeutic areas
Published: April 17, 2024 by Business Wire
Three US Senators to question Novo Nordisk over the discontinuation of Levemir, a long-acting insulin, just before a significant price cut was due to take effect; over seven million patients in the US rely on insulin
Published: April 17, 2024 by ForeignAffairs.co.nz
Phase 3 study of Roche's OCREVUS subcutaneous injection shows near-complete suppression of multiple sclerosis relapse activity and lesions; approval anticipated from FDA and EMA in 2024
Published: April 17, 2024 by F. Hoffmann-La Roche Ltd. (Roche)
Eli Lilly reports tirzepatide injectable significantly reduced sleep apnea in Phase 3 trials, achieving up to 63% reduction in the apnea-hypopnea index, a measure of sleep apnea severity; the drug also led to significant weight loss
Published: April 17, 2024 by Eli Lilly & Co.
Microbion to present its diabetic foot infection treatment, pravibismane, at the Advanced Wound Care Summit USA on April 17; the topical treatment demonstrates promising results, reportedly decreasing ulcer size and reducing the risk of amputation
Published: April 15, 2024 by PR Newswire

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count